Disease severity does not affect the interval between IBD diagnosis and the development of CRC: Results from two large, Dutch case series

Journal of Crohn's and Colitis

Volumn 6, Issue 4, 2012, Pages 435-440

  Mooiweer, Erik ^a   Baars, Judith E ^b   Lutgens, Maurice W M D ^a   Vleggaar, Frank ^a   van Oijen, Martijn ^a   Siersema, Peter D ^a   Kuipers, Ernst J ^b   van der Woude, C Janneke ^b   Oldenburg, Bas ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Colorectal cancer; General hospitals; Inflammatory bowel disease; Referral centers

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; COLON RESECTION; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENTERITIS; FEMALE; FOLLOW UP; GENERAL HOSPITAL; HUMAN; INTESTINE ENDOSCOPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROCTOCOLECTOMY; RETROSPECTIVE STUDY;

ADULT; AGE FACTORS; AGED; COLORECTAL NEOPLASMS; FEMALE; HOSPITALS, GENERAL; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NETHERLANDS; REFERRAL AND CONSULTATION; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; YOUNG ADULT;

EID: 84860209143     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.09.014     Document Type: Article

References (25)

1. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001 April, 48(4):526-535.
2. Gillen C.D., Walmsley R.S., Prior P., Andrews H.A., Allan R.N. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994 November, 35(11):1590-1592.
3. Ekbom A., Helmick C., Zack M., Adami H.O. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990 August 11, 336(8711):357-359.
4. Cairns S.R., Scholefield J.H., Steele R.J., Dunlop M.G., Thomas H.J., Evans G.D., et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010 May, 59(5):666-689.
5. Farraye F.A., Odze R.D., Eaden J., Itzkowitz S.H., McCabe R.P., Dassopoulos T., et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010 February, 138(2):738-745.
6. Jess T., Loftus E.V., Velayos F.S., Harmsen W.S., Zinsmeister A.R., Smyrk T.C., et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology 2006 April, 130(4):1039-1046.
7. Bernstein C.N., Blanchard J.F., Kliewer E., Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001 February 15, 91(4):854-862.
8. Devroede G.J., Taylor W.F., Sauer W.G., Jackman R.J., Stickler G.B. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 1971 July 1, 285(1):17-21.
9. Winther K.V., Jess T., Langholz E., Munkholm P., Binder V. Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol 2004 December, 2(12):1088-1095.
10. Rutter M., Saunders B., Wilkinson K., Rumbles S., Schofield G., Kamm M., et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004 February, 126(2):451-459.
11. Casparie M., Tiebosch A.T., Burger G., Blauwgeers H., van de PA, van Krieken J.H., et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 2007, 29(1):19-24.
12. Lutgens M.W., Vleggaar F.P., Schipper M.E., Stokkers P.C., van der Woude C.J., Hommes D.W., et al. High frequency of early colorectal cancer in inflammatory bowel disease. Gut 2008 September, 57(9):1246-1251.
13. Baars J.E., Looman C.W., Steyerberg E.W., Beukers R., Tan A.C., Weusten B.L., et al. The Risk of Inflammatory Bowel Disease-Related Colorectal Carcinoma Is Limited: Results From a Nationwide Nested Case-Control Study. Am J Gastroenterol 2010 November 2.
14. Sugita A., Sachar D.B., Bodian C., Ribeiro M.B., Aufses A.H. Greenstein AJ. Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut 1991 February, 32(2):167-169.
15. Gyde S.N., Prior P., Allan R.N., Stevens A., Jewell D.P., Truelove S.C., et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 1988 February, 29(2):206-217.
16. Karvellas C.J., Fedorak R.N., Hanson J., Wong C.K. Increased risk of colorectal cancer in ulcerative colitis patients diagnosed after 40 years of age. Can J Gastroenterol 2007 July, 21(7):443-446.
17. Ekbom A., Helmick C., Zack M. Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990 November 1, 323(18):1228-1233.
18. Soderlund S., Granath F., Brostrom O., Karlen P., Lofberg R., Ekbom A., et al. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males. Gastroenterology 2010 May, 138(5):1697-1703.
19. Bernstein C.N., Blanchard J.F., Rawsthorne P., Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 2001 April, 96(4):1116-1122.
20. Vavricka S.R., Brun L., Ballabeni P., Pittet V., Prinz Vavricka B.M., Zeitz J., et al. Frequency and Risk Factors for Extraintestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort. Am J Gastroenterol 2010 January, 106(1):110-119.
21. Claessen M.M., Vleggaar F.P., Tytgat K.M., Siersema P.D., van Buuren H.R. High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol 2009 January, 50(1):158-164.
22. Kornfeld D., Ekbom A., Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut 1997 October, 41(4):522-525.
23. Shetty K., Rybicki L., Brzezinski A., Carey W.D., Lashner B.A. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1999 June, 94(6):1643-1649.
24. Rutter M.D., Saunders B.P., Wilkinson K.H., Rumbles S., Schofield G., Kamm M.A., et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 2004 December, 53(12):1813-1816.
25. Velayos F.S., Liu L., Lewis J.D., Allison J.E., Flowers N., Hutfless S., et al. Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system. Gastroenterology 2010 November, 139(5):1511-1518.